Literature DB >> 19100195

[Infections associated with prosthetic heart valves, vascular prostheses, and cardiac pacemakers and defibrillators].

Benito Almirante1, José M Miró.   

Abstract

The implantation of biological or mechanical heart valves, pacemakers, defibrillators, and prosthetic vascular grafts can save the life of patients with valvular heart disease, conduction disorders, arrhythmia, or vascular disease. The use of these devices has increased in the general population. Antibiotic prophylaxis is indicated to prevent cardiovascular device-related infections, which are uncommon, but have high associated morbidity and mortality. We review the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of these infections. Staphylococci are the most common etiological agents, and the infection is thought to result from contamination during device implantation or in the early postoperative period. Positive blood culture status, and diagnostic imaging (transesophageal echocardiography, computed tomography, magnetic resonance imaging) and nuclear medicine study (scintigraphy using labeled leukocytes) are the basic tools to establish the diagnosis. Treatment is complex and requires prolonged antibiotic administration targeting the isolated organisms, and device removal to attain cure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100195     DOI: 10.1016/s0213-005x(08)75281-9

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  5 in total

1.  An unusual looking pacemaker infection imaged with 18F-FDG PET/CT.

Authors:  Sophie Turpin; Raymond Lambert; Nancy Poirier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-07       Impact factor: 9.236

2.  Recommendations on nuclear and multimodality imaging in IE and CIED infections.

Authors:  Paola Anna Erba; Patrizio Lancellotti; Isidre Vilacosta; Oliver Gaemperli; Francois Rouzet; Marcus Hacker; Alberto Signore; Riemer H J A Slart; Gilbert Habib
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-24       Impact factor: 9.236

3.  [Pacemaker infection with Mycobacterium neoaurum].

Authors:  N Bastón-Paz; M Bolaños-Rivero; M Hernández-Cabrera; A M Martín-Sánchez
Journal:  Rev Esp Quimioter       Date:  2018-06-27       Impact factor: 1.553

4.  DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.

Authors:  Carmen Hidalgo-Tenorio; David Vinuesa; Antonio Plata; Pilar Martin Dávila; Simona Iftimie; Sergio Sequera; Belén Loeches; Luis Eduardo Lopez-Cortés; Mari Carmen Fariñas; Concepción Fernández-Roldan; Rosario Javier-Martinez; Patricia Muñoz; Maria Del Mar Arenas-Miras; Francisco Javier Martínez-Marcos; Jose Maria Miró; Carmen Herrero; Elena Bereciartua; Samantha E De Jesus; Juan Pasquau
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-10-19       Impact factor: 3.944

5.  Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.

Authors:  Carmen Hidalgo-Tenorio; Juan Gálvez; Francisco Javier Martínez-Marcos; Antonio Plata-Ciezar; Javier De La Torre-Lima; Luis Eduardo López-Cortés; Mariam Noureddine; José M Reguera; David Vinuesa; Maria Victoria García; Guillermo Ojeda; Rafael Luque; José Manuel Lomas; Jose Antonio Lepe; Arístides de Alarcón
Journal:  BMC Infect Dis       Date:  2020-02-21       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.